4Filed Jul 16, 8:00 PM ET

Natera (NTRA) Co‑Founder/Director Sheena Jonathan Sells Shares

$NTRA · Natera, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Natera (NTRA) Co‑Founder/Director Sheena Jonathan Sells Shares

What Happened

  • Sheena Jonathan, Director and Co‑Founder of Natera (NTRA), sold a total of 1,500 shares in multiple open‑market transactions on July 15, 2026, generating aggregate proceeds of approximately $410,823.
  • Individual reported dispositions:
    • 450 sh @ $273.05 = $122,871
    • 90 sh @ $274.26 = $24,683
    • 170 sh @ $275.26 = $46,795
    • 40 sh @ $276.38 = $11,055
    • 390 sh @ $273.01 = $106,473
    • 100 sh @ $273.68 = $27,368
    • 180 sh @ $274.99 = $49,497
    • 80 sh @ $276.01 = $22,081
  • These were sales (transaction code S), not purchases or option exercises.

Key Details

  • Transaction date: July 15, 2026; Form 4 filed July 17, 2026 (filed timely).
  • Total sold: 1,500 shares for about $410,823 in aggregate proceeds.
  • Several reported prices are weighted averages; the filing includes footnote ranges for the per‑share prices (prices in the individual trades ranged roughly from $272.56 to $276.38 per share). The filer offers to provide a full breakdown on request.
  • Footnote F1: Sales were effected pursuant to a Rule 10b5‑1 trading plan adopted June 7, 2024.
  • Footnote F3: Some shares are held for the benefit of trust beneficiaries and the reporting person disclaims beneficial ownership over those securities (per the filing).
  • Shares owned after the transaction are not specified in the provided filing excerpt.

Context

  • A Rule 10b5‑1 plan is a prearranged trading program that lets insiders sell shares according to a set schedule; such sales are often routine and reflect preexisting instructions rather than a new, immediate view of the company.
  • Weighted‑average pricing and multiple sales across a single day are common in open‑market executions; the filing’s footnotes provide price ranges and offer a breakdown on request for investors who want exact per‑trade pricing.